GlassScriptPhysician profile
David A Josephson
NPI 1871597559
$18,654.57
in general payments reported to CMS, 2019-2025
78 companies · $2,719 in 2025
The $2,719 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,890 · 2020: $1,853 · 2021: $1,888 · 2022: $2,998 · 2023: $3,307 · 2024: $2,999 · 2025: $2,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,024.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,954.08 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,979.83 | 2019-2025 | |
| Biogen, INC. | $994.93 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Kyowa Kirin, INC. | $775.00 | 2020 | |
| Lilly USA, LLC | $768.31 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Ucb, INC. | $733.64 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Genzyme Corporation | $682.99 | 2019-2025 | |
| Amgen INC. | $680.58 | 2019-2025 | Uplizna, Aimovig |
| Supernus Pharmaceuticals, INC. | $593.07 | 2019-2020 | |
| Emd Serono, INC. | $584.20 | 2019-2025 | Mavenclad |
| Eisai INC. | $565.66 | 2019-2024 | |
| Mdd US Operations, LLC | $452.91 | 2019-2025 | Apokyn, Apokyn |
| Allergan, INC. | $384.90 | 2019-2022 | |
| Genentech USA, INC. | $371.10 | 2019-2023 | Ocrevus, Enspryng |
| Harmony Biosciences LLC | $343.20 | 2021-2025 |
Show all 78 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Josephson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.